Bavarian Nordic A/S
BAVA
Rankning i aktier
#5045
Hellerup, Denmark-based Bavarian Nordic A/S, founded in 1992, specializes in... Hellerup, Denmark-based Bavarian Nordic A/S, founded in 1992, specializes in the research, production, and global distribution of vital, life-saving vaccines. The company's commercialized offerings include non-replicating vaccines for smallpox and monkeypox, marketed as IMVAMUNE, IMVANEX, and JYNNEOS. Additionally, their portfolio features Rabipur/RabAvert for rabies prevention, Encepur for tick-borne encephalitis, and MVABEA, an Ebola vaccine. Bavarian Nordic also maintains a robust pipeline of investigational treatments. This includes MVA-BN (freeze-dried), which has successfully completed Phase III clinical trials for smallpox; MVA-BN RSV, currently in Phase III development for respiratory syncytial virus; ABNCoV2, which completed Phase II trials targeting SARS-CoV-2; and TAEK-VAC, presently in Phase I/II trials for advanced HER2 and brachyury-expressing cancers. The firm engages in key partnerships, notably a license and collaboration agreement with AdaptVac, and licensing agreements with both the National Cancer Institute and the Public Health Service. Bavarian Nordic operates across a wide international footprint, with a presence in countries such as the United States, Germany, Belgium, France, Canada, the United Kingdom, Hong Kong, Saudi Arabia, Australia, Switzerland, and numerous other global markets.
Aktiekurs
$37.76
Marknadsvärde
$2.87B
Förändring (1 dag)
0.00%
Förändring (1 år)
1.44%
Land
DK
Handel Bavarian Nordic A/S (BAVA)
Kategori
Healthcare
Marknadsvärde för Bavarian Nordic A/S(BAVA)
Marknadsvärde: $2.87B
Från och med October 2026 har Bavarian Nordic A/S ett börsvärde på $2.87B. Detta gör Bavarian Nordic A/S till det 5045th mest värdefulla företaget i världen enligt våra data. Börsvärdet, även kallat market cap, är det totala marknadsvärdet av ett börsnoterat företags utestående aktier och används ofta för att uppskatta ett företags värde.
Marknadsvärdehistorik för Bavarian Nordic A/S från 2003 till 2026
BAVA jämfört med topp 5 mest populära stocks
